ArticleClinicoEconomics and outcomes research : CEOR2025

Cost-Benefit Analysis of Genetic Testing as a Prenatal Diagnostic Tool for Thalassemia: A Single-Center Study From Central Thailand.

Kwandao Malasai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.